1,734
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Self-reported IBS and gastrointestinal symptoms in the general population are associated with asthma, drug consumption and a family history of gastrointestinal diseases

& ORCID Icon
Received 13 Dec 2021, Accepted 12 Jan 2022, Published online: 01 Feb 2022

References

  • Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–1407.
  • Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study. Gastroenterology. 2021;160(1):99–114.
  • Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15(1):35.
  • Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a Meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–721.
  • Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and Meta-analysis. Gastroenterology. 2017;152(5):1042–1054.
  • Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122(4):1140–1156.
  • Wang B, Duan R, Duan L. Prevalence of sleep disorder in irritable bowel syndrome: a systematic review with Meta-analysis. Saudi J Gastroenterol. 2018;24(3):141–150.
  • Ibrahim NK, Battarjee WF, Almehmadi SA. Prevalence and predictors of irritable bowel syndrome among medical students and interns in king Abdulaziz University, Jeddah. Libyan J Med. 2013;8:21287.
  • Fosnes GS, Lydersen S, Farup PG. Constipation and diarrhoea - common adverse drug reactions? A cross sectional study in the general population. BMC Clin Pharmacol. 2011;11:2.
  • Van Oudenhove L, Crowell MD, Drossman DA, et al. Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1355–1367.e2.
  • Brunkwall L, Jönsson D, Ericson U, et al. The malmö offspring study (MOS): design, methods and first results. Eur J Epidemiol. 2021;36(1):103–116.
  • Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–1491.
  • Bengtsson M, Ohlsson B, Ulander K. Development and psychometric testing of the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2007;7(1):16.
  • Bengtsson M, Persson J, Sjölund K, et al. Further validation of the visual analogue scale for irritable bowel syndrome after use in clinical practice. Gastroenterol Nurs. 2013;36(3):188–198.
  • FASS. Metoprolol Sandoz [Internet]. Läkemedelsindustriföreningen; 2018. [updated 2018-04-26; cited 2021 Mar 15]. Available from: https://www.fass.se/LIF/product?userType=0&nplId=20041011000027
  • McDonald JH. Handbook of biological statistics. 3rd ed. Baltimore (MD): Sparky House publishing; 2014. [cited 2021 Mar 25]. Available from: http://www.biostathandbook.com/multiplecomparisons.html.
  • Greer JA, Applebaum AJ, Jacobsen JC, et al. Understanding and addressing the role of coping in palliative care for patients with advanced cancer. J Clin Oncol. 2020;38(9):915–925.
  • Gardiner CP, Singh P, Ballou S, et al. Symptom severity and clinical characteristics of patients with bloating. Neurogastroenterol Motil. 2021;e14229. DOI:https://doi.org/10.1111/nmo.14229
  • Hamrefors V, Fedorowski A, Ohlsson B. Susceptibility to diarrhea is related to hemodynamic markers of sympathetic activation in the general population. Scand J Gastroenterol. 2019;54:1–7.
  • Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001;121(4):799–804.
  • Waehrens R, Zöller B, Sundquist J, et al. A swedish national adoption study of risk of irritable bowel syndrome (IBS). BMJ Open Gastroenterol. 2017;4(1):e000156.
  • Levy RL, Whitehead WE, Von Korff MR, et al. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol. 2000;95(2):451–456.
  • Whitehead WE, Winget C, Fedoravicius AS, et al. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci. 1982;27(3):202–208.
  • Makins R, Ballinger A. Gastrointestinal side effects of drugs. Expert Opin Drug Saf. 2003;2(4):421–429.
  • Poitras P, Gougeon A, Binn M, et al. Extra digestive manifestations of irritable bowel syndrome: intolerance to drugs? Dig Dis Sci. 2008;53(8):2168–2176.
  • Tielemans MM, van Rossum LG, Eikendal T, et al. Gastrointestinal symptoms in NSAID users in an ‘average risk population’: results of a large population-based study in randomly selected dutch inhabitants. Int J Clin Pract. 2014;68(4):512–519.
  • Abrahamsson H, Dotevall G. Effects of propranolol on colonic pressure in patients with irritable bowel syndrome. Scand J Gastroenterol. 1981;16(8):1021–1024.
  • Barron AJ, Zaman N, Cole GD, et al. Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information. Int J Cardiol. 2013;168(4):3572–3579.
  • Ford AC, Marwaha A, Lim A, et al. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010;8(5):401–409.
  • Lovell RM, Ford AC. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a Meta-analysis. Am J Gastroenterol. 2012;107(12):1793–1801.
  • Compare D, Pica L, Rocco A, et al. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest. 2011;41(4):380–386.
  • Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18(8):595–607.
  • Shen TC, Lin CL, Wei CC, Chen CH, Tu CY, et al. Bidirectional association between asthma and irritable bowel syndrome: two population-based retrospective cohort studies. PLoS One. 2016;11(4):e0153911.
  • Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 2008;100(1):49–53.
  • Riedl A, Schmidtmann M, Stengel A, Goebel M, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res. 2008;64(6):573–582.
  • Kettell J, Jones R, Lydeard S. Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. Br J Gen Pract. 1992;42(364):459–461.
  • Palsson OS, Whitehead WE, Van Tilburg MAL, et al. Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology. 2016;150(6):1481–1491.
  • Vork L, Weerts ZZRM, Mujagic Z, et al. Rome III vs. Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study. Neurogastroenterol Motil. 2018;30(2):e13189.
  • Van den Houte K, Carbone F, Pannemans J, et al. Prevalence and impact of self-reported irritable bowel symptoms in the general population. United Eur Gastroenterol J. 2019;7(2):307–315.